CIP
AMGN icon

Champlain Investment Partners’s Amgen AMGN Stock Holding History

Champlain Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,600
Closed -$267K – 122
2016
Q3 		$267K Hold
1,600
– – ﹤0.01% 132
2016
Q2 		$243K Buy
+1,600
New +$249K ﹤0.01% 134

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Champlain Investment Partners's AMGN Position: Q4 2016 in Review

Champlain Investment Partners sold out of Amgen (AMGN) in Q4 2016, closing a stake of 1,600 shares — an estimated $267K sold.

Champlain Investment Partners first reported a position in AMGN in Q2 2016 and held it in 2 quarters. The position peaked at $267K in Q3 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Champlain Investment Partners reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Champlain Investment Partners sold 1,600 Amgen shares in Q4 2016, an estimated $267K.
  • Champlain Investment Partners first reported a position in Amgen in Q2 2016 and held it in 2 quarters.
  • Champlain Investment Partners's Amgen position peaked at $267K in Q3 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Champlain Investment Partners's 13F filing for Q4 2016, filed 13 Feb 2017.